Buy Avanos Medical

Logo for stock AVNS (Avanos Medical)

Amount

£
GBP

Latest price

$12.41
(£1.00 = $1.321)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$570.899M

P/E ratio

-1.46

EPS

-$8.524

Beta

1.15

Dividend rate

N/A

Dividend yield

N/A

About

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment, which provides its medical device products to healthcare providers and patients with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Its surgical pain and recovery products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. Its interventional pain solutions include COOLIEF chronic pain products, OrthogenRx knee osteoarthritis hyaluronic acid (HA) pain relief injection products (GenVisc and TriVisc) and Trident radiofrequency ablation (RFA) products.

CEO

N/A

Employees

2,227

Sector

Health

Company HQ

ALPHARETTA, United States of America

Website

News

Logo for news article #0 (AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK)

AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK

Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.

Zacks Investment Research

April 03, 2025

Logo for news article #1 (Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025)

Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025

ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product availability into the future, and providing a seamless experience for healthcare providers and patients.

PRNewsWire

April 02, 2025

Logo for news article #2 (New Strong Sell Stocks for March 24th)

New Strong Sell Stocks for March 24th

AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.

Zacks Investment Research

March 24, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.